Aurobindo Pharma Ltd vs Themis Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 13, 2026

Key Highlights

The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1472 as of 12 Jun 15:30 . The P/E Ratio of Aurobindo Pharma Ltd changed from 9.7 on March 2021 to 19.3 on March 2025 . This represents a CAGR of 14.75% over 5 yearsThe P/E Ratio of Themis Medicare Ltd changed from 7.2 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 44.46% over 5 years The Market Cap of Aurobindo Pharma Ltd changed from ₹ 51653 crore on March 2021 to ₹ 67951 crore on March 2025 . This represents a CAGR of 5.64% over 5 yearsThe Market Cap of Themis Medicare Ltd changed from ₹ 257.55 crore on March 2021 to ₹ 1349 crore on March 2025 . This represents a CAGR of 39.28% over 5 years The revenue of Aurobindo Pharma Ltd for the Mar '26 is ₹ 8970 crore as compare to the Dec '25 revenue of ₹ 8833 crore. This represent the growth of 1.54% The revenue of Themis Medicare Ltd for the Mar '26 is ₹ 87.13 crore as compare to the Dec '25 revenue of ₹ 96.93 crore. This represent the decline of -10.11% The ebitda of Aurobindo Pharma Ltd for the Mar '26 is ₹ 1867 crore as compare to the Dec '25 ebitda of ₹ 1896 crore. This represent the decline of -1.51% The ebitda of Themis Medicare Ltd for the Mar '26 is ₹ 14.36 crore as compare to the Dec '25 ebitda of ₹ 15.73 crore. This represent the decline of -8.71% The net profit of Aurobindo Pharma Ltd changed from ₹ 918.22 crore to ₹ 920.84 crore over 8 quarters. This represents a CAGR of 0.14% The net profit of Themis Medicare Ltd changed from ₹ 24.68 crore to ₹ 8.89 crore over 8 quarters. This represents a CAGR of -39.98% The Dividend Payout of Aurobindo Pharma Ltd changed from 7.53 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Themis Medicare Ltd changed from 14.84 % on March 2021 to 19.23 % on March 2025 . This represents a CAGR of 5.32% over 5 years .

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in December 1986 as a private limited company.
Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Themis Medicare Ltd

Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
The Company is principally engaged in the business of manufacturing of finished formulations and synthetic Active Pharmaceutical Ingredients. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

FAQs for the comparison of Aurobindo Pharma Ltd and Themis Medicare Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Themis Medicare Ltd?

Market cap of Aurobindo Pharma Ltd is 85,508 Cr while Market cap of Themis Medicare Ltd is 960 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Themis Medicare Ltd?

The stock performance of Aurobindo Pharma Ltd and Themis Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Themis Medicare Ltd?

As of June 13, 2026, the Aurobindo Pharma Ltd stock price is INR ₹1472.25. On the other hand, Themis Medicare Ltd stock price is INR ₹104.25.

How do dividend payouts of Aurobindo Pharma Ltd and Themis Medicare Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Themis Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.